CAPTRUST Financial Advisors
IONS icon

CAPTRUST Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Sell
5,000
-293
-6% -$23.1K ﹤0.01% 2233
2025
Q4 		$419K Buy
+5,293
New +$399K ﹤0.01% 2012
2024
Q1 		– Sell
-10,108
Closed -$511K – 2397
2023
Q4 		$511K Sell
10,108
-158
-2% -$7.57K ﹤0.01% 1724
2023
Q3 		$466K Buy
10,266
+939
+10% +$38.7K ﹤0.01% 1690
2023
Q2 		$383K Sell
9,327
-131
-1% -$5.03K ﹤0.01% 1799
2023
Q1 		$338K Sell
9,458
-70
-0.7% -$2.63K ﹤0.01% 1662
2022
Q4 		$360K Buy
+9,528
New +$401K ﹤0.01% 1524
2022
Q3 		– Sell
-1,429
Closed -$53K – 3036
2022
Q2 		$53K Buy
1,429
+249
+21% +$9.39K ﹤0.01% 2703
2022
Q1 		$44K Sell
1,180
-121
-9% -$3.96K ﹤0.01% 2882
2021
Q4 		$40K Sell
1,301
-1,171
-47% -$36.9K ﹤0.01% 2832
2021
Q3 		$83K Buy
2,472
+576
+30% +$21.7K ﹤0.01% 2218
2021
Q2 		$76K Sell
1,896
-77
-4% -$3.02K ﹤0.01% 2223
2021
Q1 		$89K Buy
1,973
+420
+27% +$23.4K ﹤0.01% 2040
2020
Q4 		$88K Hold
1,553
– – ﹤0.01% 1563
2020
Q3 		$74K Hold
1,553
– – ﹤0.01% 1480
2020
Q2 		$93K Buy
1,553
+104
+7% +$5.79K ﹤0.01% 1370
2020
Q1 		$68K Buy
+1,449
New +$80.8K ﹤0.01% 1273
2019
Q4 		– Sell
-496
Closed -$30K – 1388
2019
Q3 		$30K Buy
496
+300
+153% +$19.6K ﹤0.01% 1168
2019
Q2 		$13K Buy
196
+154
+367% +$10.9K ﹤0.01% 1426
2019
Q1 		$3K Sell
42
-44
-51% -$2.84K ﹤0.01% 1631
2018
Q4 		$5K Hold
86
– – ﹤0.01% 1330
2018
Q3 		$4K Hold
86
– – ﹤0.01% 1394
2018
Q2 		$4K Buy
+86
New +$3.81K ﹤0.01% 1347
2018
Q1 		– Sell
-86
Closed -$4K – 1349
2017
Q4 		$4K Hold
86
– – ﹤0.01% 1144
2017
Q3 		$4K Buy
+86
New +$4.5K ﹤0.01% 499

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAPTRUST Financial Advisors's IONS Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 5.5% in Q1 2026, selling an estimated $23.1K and leaving 5,000 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

CAPTRUST Financial Advisors first reported a position in IONS in Q3 2017 and has held it in 25 quarters since. The position peaked at $511K in Q4 2023. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • CAPTRUST Financial Advisors held 5,000 shares of Ionis Pharmaceuticals worth $375K as of Q1 2026.
  • CAPTRUST Financial Advisors sold 293 Ionis Pharmaceuticals shares in Q1 2026, an estimated $23.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2233 holding.
  • CAPTRUST Financial Advisors first reported a position in Ionis Pharmaceuticals in Q3 2017 and has held it in 25 quarters since.
  • CAPTRUST Financial Advisors's Ionis Pharmaceuticals position peaked at $511K in Q4 2023.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.